PRISM BioLab Co (206A.T) Aktie Kurs

PRISM BioLab Co Ltd is a JP-based company operating in Pharmaceuticals industry. The company is headquartered in Fujisawa-Shi, Kanagawa-Ken and currently employs 17 full-time employees. The company went IPO on 2024-07-02. PRISM BioLab Co Ltd is a Japan-based company mainly engaged in the drug discovery business. The firm operates through Japan drug discovery business segment. The firm builds a new drug discovery platform and develops new drugs. The firm conducts research and development of pharmaceuticals using their owned drug discovery platform technology PepMetics technology. There are two business models. The in-house development business is engaged in the select of drug discovery targets and creates programs in-house. The joint development business creates programs using their owned technology to target drug discovery targets for pharmaceutical companies.